About Egetis
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment
PledPharma AB was founded in 2006 and is listed on Nasdaq Stockholm’s main market, since October 31, 2019.
On November 3, 2020, the Company acquired Rare Thyroid Therapeutics International AB (RTT). Together with RTT, the new company Egetis Therapeutics AB was formed.
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: [email protected]
